Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction
Condition: Heart Failure Interventions: Drug: Sacubitril-valsartan; Drug: Enalapril; Drug: placebo; Drug: Placebo Sponsors: Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań; Medical Research Agency, Poland; Medical University of Bialystok; University of Opole; Medical University of Gdańsk; Medical University of Silesia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Diovan | Enalapril | Heart | Heart Failure | Hospitals | Poland Health | Research